Loading
A phase 2 trial of tislelizumab in colorectal cancer, run by Memorial Sloan Kettering Cancer Center, now recruiting.
Tislelizumab in People With Colorectal Cancer is a phase 2, interventional study registered as NCT06529523 by Memorial Sloan Kettering Cancer Center, with a registry enrolment figure of 40 participants, started 2024-07-26 and due to reach its primary completion in 2028-07. Interventions recorded: Tislelizumab. Conditions listed: Colorectal Cancer. Primary outcome: objective response rate of PD-1 blockade with tislelizumab. Colorectal eligibility wording from the registry: "* Surgically sterile (ie, through bilateral salpingectomy, bilateral oophorectomy, or hysterectomy)". Sites: Nigeria, United States. No results are recorded here; the registry entry is the source.
Shares BeOne Medicines (formerly BeiGene), Tislelizumab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Tislelizumab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Tislelizumab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Tislelizumab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Tislelizumab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Tislelizumab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Tislelizumab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Tislelizumab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.